Aspen Insurance Holdings Ltd · NYSE:AHL/PE

Aspen Insurance — Merger or Acquisition (July 2014)

45 slides from Aspen Insurance's merger presentation, Jul 1, 2014

  1. Slide 1: Endurance and Aspen: Creating a Global Leader in Specialty Insurance and Reinsurance

    Slide 1: Endurance and Aspen: Creating a Global Leader in Specialty Insurance and Reinsurance

    Endurance Endurance and Aspen: Creating a Global Leader in Specialty Insurance and Reinsurance July 2014

  2. Slide 2: Forward looking statements & other information

    Slide 2: Forward looking statements & other information

    Forward looking statements & other information Cautionary Note Regarding Forward Looking Statements Some of the statements in this presentation may include, and Endurance may make related oral, forward-looking statements which reflect our current views with respect to future events and financial per

  3. Slide 3: Forward looking statements & other information (continued)

    Slide 3: Forward looking statements & other information (continued)

    Forward looking statements & other information (continued) Regulation G Disclaimer In this presentation, management has included and discussed certain non-GAAP measures, including return on equity, combined ratio, net premiums written and diluted book value per share. Management believes that these

  4. Slide 4: Table of Contents

    Slide 4: Table of Contents

    Table of Contents Executive Summary Strategic Rationale and Compelling Value of Endurance’s Proposal Endurance’s Actions to Expedite the Transaction Appendix 4 Endurance

  5. Slide 5: Executive Summary

    Slide 5: Executive Summary

    Endurance Executive Summary

  6. Slide 6: Industry Overview

    Slide 6: Industry Overview

    Industry Overview Primary insurers provide insurance coverage (a “promise to pay”) in return for premiums Investment income is earned on the premiums, which are invested before claims are paid out Reinsurers provide insurance for insurance companies looking to lay-off (cede) a portion of their assum

  7. Slide 7: Endurance Overview

    Slide 7: Endurance Overview

    Endurance Overview Company Description Endurance Specialty Holdings Ltd., through its subsidiaries, underwrites specialty lines of property and casualty insurance and reinsurance worldwide Endurance writes agriculture, casualty and other specialty, professional and property lines of insurance and ca

  8. Slide 8: Endurance Overview (cont'd)

    Slide 8: Endurance Overview (cont'd)

    Endurance Overview (cont’d) Endurance’s strategy has been strongly supported by the investment community Share Price Performance: Endurance vs. Peers (1) 1/1/2013 – 4/11/2014 % 50 40 30 20 10 0 +36% +29% +23% Jan-13 Apr-13 Jul-13 Oct-13 Jan-14 Apr-14 ENH AHL Peers Average Notes 1. Peers include ACGL

  9. Slide 9: Aspen Overview

    Slide 9: Aspen Overview

    Aspen Overview Company Description Aspen Insurance Holdings Limited, through its subsidiaries, operates in insurance and reinsurance businesses worldwide Aspen’s insurance segment offers property insurance, casualty insurance, marine, energy and construction liability and other specialty insurance p

  10. Slide 10: Aspen Overview (cont'd)

    Slide 10: Aspen Overview (cont'd)

    Aspen Overview (cont’d) Performance has consistently lagged peers Aspen faces long-term challenges in terms of scale, competition and global breadth Performance has consistently lagged its competitors, including Endurance, across most key metrics On its own, Aspen has no obvious catalyst to meaningf

  11. Slide 11: A Unique Opportunity to Create a Global Leader in the Specialty Insurance and Reinsurance Sector

    Slide 11: A Unique Opportunity to Create a Global Leader in the Specialty Insurance and Reinsurance Sector

    Aspen and Endurance: A Unique Opportunity to Create a Global Leader in the Specialty Insurance and Reinsurance Sector Increased Scale and Market Presence Diversified Platform Across Products and Geographies Strong Balance Sheet and Capital Position Enhanced Profitability Combination creates an enter

  12. Slide 12: Transaction Terms

    Slide 12: Transaction Terms

    Transaction Terms Endurance’s proposal provides compelling value for Aspen shareholders while generating significant earnings and ROE accretion for Endurance shareholders Transaction Proposal Value Consideration Financing Endurance CEO Investment Pro Forma Ownership Financial Benefits Endurance to a

  13. Slide 13: Endurance Offer for Aspen

    Slide 13: Endurance Offer for Aspen

    Endurance Offer for Aspen Per Aspen Share (1) Premium to Aspen Share Price % Premium to Unaffected Share Price % Premium to Unaffected All-time High (2) Valuation Multiples P/BV (12/31/13) P/BV (3/31/14) P/E 14E (3) P/E 15E (3) 4/14/2014 Initial Offer 6/2/2014 Increased Offer $47.50 20.7% 14.7% 1.16

  14. Slide 14: Clear Contrast in Corporate Governance

    Slide 14: Clear Contrast in Corporate Governance

    Clear Contrast in Corporate Governance Aspen’s Poor Corporate Governance Practices Board is classified, with directors serving three year terms Directors can only be removed “for cause” Board adopted a “poison pill” in April 2014 that prevents shareholders from realizing the benefits of transaction

  15. Slide 15: Transaction Timeline – Endurance's Commitment and Aspen's Entrenchment

    Slide 15: Transaction Timeline – Endurance's Commitment and Aspen's Entrenchment

    Transaction Timeline – Endurance’s Commitment and Aspen’s Entrenchment January 30, 2014: John Charman approaches Aspen CEO to discuss a strategic transaction between Endurance and Aspen February 13, 2014: Aspen CEO advises that Aspen declines to meet with Endurance February 18, 2014: Endurance deliv

  16. Slide 16: Aspen's Continued Entrenchment has Required Endurance to Provide a Path Forward

    Slide 16: Aspen's Continued Entrenchment has Required Endurance to Provide a Path Forward

    Aspen’s Continued Entrenchment has Required Endurance to Provide a Path Forward to Aspen Shareholders Actions to expedite transaction further demonstrate Endurance’s commitment to pursuing this transaction while providing Aspen shareholders multiple means to voice support and complete transaction in

  17. Slide 17: Strategic Rationale and Compelling Value of Endurance's Proposal

    Slide 17: Strategic Rationale and Compelling Value of Endurance's Proposal

    Endurance Strategic Rationale and Compelling Value of Endurance’s Proposal

  18. Slide 18: Key Benefits of Endurance's Proposal

    Slide 18: Key Benefits of Endurance's Proposal

    Key Benefits of Endurance’s Proposal 1 Value 2 Scale 3 Diversification 4 Financial Strength 5 Outlook Aspen Standalone Valuation has trailed that of peers over the past 5 years: up only 66% vs. 96% for peers (1) Historically traded below book value Disadvantaged relative to peers due to lack of scal

  19. Slide 19: Proposed Valuation Well Above Aspen's Historical Trading Prices

    Slide 19: Proposed Valuation Well Above Aspen's Historical Trading Prices

    Proposed Valuation Well Above Aspen’s Historical Trading Prices Aspen Share Price – Last 5 Years 4/11/2009 – 4/11/2014 $50 $49.50 $40 $39.37 $30 $20 Apr-09 Apr-10 Apr-11 Apr-12 Apr-13 Historical Share Price Endurance Purchase Price Aspen P/BV – Last 5 Years 4/11/2009 – 4/11/2014 1.25x 1.16x 1.00x 0.

  20. Slide 20: Proposal Provides Compelling Value for Aspen Shareholders

    Slide 20: Proposal Provides Compelling Value for Aspen Shareholders

    Proposal Provides Compelling Value for Aspen Shareholders Substantial Premium to Trading Prices Proposal Price Per Share $49.50 vs. Price as of 4/11/2014 $39.37 +25.7% vs. 1-month VWAP (1) $39.27 +26.1% vs. All Time High (2) $41.43 +19.5% Attractive Valuation Multiples Proposal Price Per Share $49.5

  21. Slide 21: Comparable Transaction Analysis

    Slide 21: Comparable Transaction Analysis

    Comparable Transaction Analysis Comparison of P/BV multiples for selected Bermuda / Reinsurance transactions Aspen / Endurance 1.16x Alterra / Markel 1.07x Paris Re / Partner Re 0.98x Transatlantic / Alleghany 0.85x IPC / Validus 0.84x HarborPoint / Max Capital 0.80x Flagstone / Validus 0.73x 0.00x

  22. Slide 22: Combined Company Will Have Scale to Compete With Market Leaders

    Slide 22: Combined Company Will Have Scale to Compete With Market Leaders

    Combined Company Will Have Scale to Compete With Market Leaders Gross Written Premiums of Peer Companies $Bn, for the year ended 12/31/2013 10.0 7.7 8.0 6.0 5.6 5.3 5.2 4.7 4.2 4.0 2.7 2.7 2.6 2.4 1.9 1.6 2.0 0.7 0.6 0.0 XL PRE ENH+AHL RE AXS ACGL AWH ENH AHL VR AGII RNR MRH PTP Shareholders’ Equity

  23. Slide 23: Scale Advantages for a Combined Endurance / Aspen

    Slide 23: Scale Advantages for a Combined Endurance / Aspen

    Scale Advantages for a Combined Endurance / Aspen Strategic Advantages of a Larger Capital Base Lower cost of capital afforded by scale provides competitive advantage in the face of increasing capital market capacity Mitigates continued pricing pressures, especially in reinsurance Greater influence

  24. Slide 24: Combined Business Well Diversified Across Business Lines and Sectors

    Slide 24: Combined Business Well Diversified Across Business Lines and Sectors

    Combined Business Well Diversified Across Business Lines and Sectors Geographic and distribution diversification benefits are also achieved Full Year 2013 Gross Written Premiums Endurance Reinsurance 45% Insurance 55% Casualty & Specialty (1) Agriculture 36% 20% Property 11% Catastrophe Property 2%

  25. Slide 25: Transaction Generates Meaningful Synergies and Financial Strength

    Slide 25: Transaction Generates Meaningful Synergies and Financial Strength

    Transaction Generates Meaningful Synergies and Financial Strength Key Financial Drivers Over $100 million of annual synergies anticipated, including: – Cost savings – Underwriting improvements – Capital efficiencies – Enhanced capital management opportunities Combined Balance Sheet Strength (1) Endu

  26. Slide 26: Superior Pro Forma Financial Profile

    Slide 26: Superior Pro Forma Financial Profile

    Superior Pro Forma Financial Profile Aspen Standalone Endurance / Aspen Pro Forma (1) Shareholders’ Equity $3.4Bn (3/31/14) $5.9Bn (3/31/14) Total Debt / Capital 15% (3/31/14) 19% (3/31/14) 15% (12/31/15) Total Debt + Preferred / Capital 29% (3/31/14) 33% (3/31/14) 28% (12/31/15) Net Income – 2015E

  27. Slide 27: Aspen Underperformance Under Current Management

    Slide 27: Aspen Underperformance Under Current Management

    Aspen Underperformance Under Current Management 5 Year Performance(1) Aspen Endurance Total Return to Shareholders 83% 124% Diluted Book Value Per Share 9.4% CAGR 13.0% CAGR Growth Underwriting Profitability (Combined 96.7% 95.6% Ratio) Efficiency (Expense Ratio) 33.5% 29.0% Endurance has performed

  28. Slide 28: Analysts Forecast Limited Improvement for Aspen's Standalone ROE

    Slide 28: Analysts Forecast Limited Improvement for Aspen's Standalone ROE

    Analysts Forecast Limited Improvement for Aspen’s Standalone ROE Equity Research #1 “Thoughts on ROE Outlook: AHL’s ROE in this quarter was 14.9%, however if we normalize for cat losses and reserve releases in excess of our forecast we get ROE closer to 9%. We continue to have difficulty finding the

  29. Slide 29: Transaction Provides Substantial Premium vs. Standalone Plan

    Slide 29: Transaction Provides Substantial Premium vs. Standalone Plan

    Transaction Provides Substantial Premium vs. Standalone Plan and Significant Upside Potential to Aspen Shareholders The transaction provides Aspen shareholders the ability to achieve values meaningfully higher than Aspen’s future value implied by consensus Street estimates for Aspen’s ROE and recent

  30. Slide 30: Analysts Recognize Strategic and Financial Benefits of Combination

    Slide 30: Analysts Recognize Strategic and Financial Benefits of Combination

    Analysts Recognize Strategic and Financial Benefits of Combination and Support Engagement Equity Research #1 “We suspect that current AHL shareholders will ask the AHL board to reconsider this transaction and/or look for competitive offers. Looking over the landscape we do not see too many competito

  31. Slide 31: Endurance's Actions to Expedite the Transaction

    Slide 31: Endurance's Actions to Expedite the Transaction

    Endurance Endurance’s Actions to Expedite the Transaction

  32. Slide 32: Path for Aspen's Shareholders to Realize the Benefits of Endurance's Proposal

    Slide 32: Path for Aspen's Shareholders to Realize the Benefits of Endurance's Proposal

    Endurance’s Actions to Expedite the Transaction – Path for Aspen’s Shareholders to Realize the Benefits of Endurance’s Proposal Action 1: Special General Meeting of Aspen Shareholders Solicitation statement mailed to Aspen shareholders on June 18, 2014 seeking the support of Aspen’s common sharehold

  33. Slide 33: Actions to Expedite the Transaction – Scheme of Arrangement

    Slide 33: Actions to Expedite the Transaction – Scheme of Arrangement

    Endurance’s Actions to Expedite the Transaction – Scheme of Arrangement A Scheme of Arrangement is a court approved arrangement between a company and its shareholders that would allow Endurance to simultaneously acquire all of the outstanding Aspen common shares Solicitation seeking support of Aspen

  34. Slide 34: Committed Financing Plan

    Slide 34: Committed Financing Plan

    Committed Financing Plan – Delivering Substantial Cash Consideration to Aspen Shareholders $1.0Bn committed bridge loan facility from a syndicate led by Morgan Stanley to fund, together with cash on hand at Endurance, the cash portion of the consideration payable to Aspen’s shareholders Endurance’s

  35. Slide 35: Appendix

    Slide 35: Appendix

    —_—— Endurance Appendix ee ~s

  36. Slide 36: Insurance Industry Overview

    Slide 36: Insurance Industry Overview

    Insurance Industry Overview Insurance Overview Reinsurance Overview Premiums Commissions & Fees Insurance Purchaser P&C Broker Claims Primary Insurer Ceded Premiums Commissions & Fees P&C Broker Reinsurer Claims Two main types of reinsurance Pro Rata Losses Insurer Reinsurer % of Losses Excess of Lo

  37. Slide 37: Endurance Has Strong Foundation to Build on

    Slide 37: Endurance Has Strong Foundation to Build on

    Endurance Has Strong Foundation to Build on Strong balance sheet, diversified portfolio and robust infrastructure Strong Balance Sheet and Capital “A” ratings from AM Best and S&P $3.5 billion of total capital (as of 3/31/2014) Conservative, short-duration, AA rated investment portfolio Prudent rese

  38. Slide 38: Endurance Has an Attractive and Growing Specialty Insurance Franchise

    Slide 38: Endurance Has an Attractive and Growing Specialty Insurance Franchise

    Endurance Has an Attractive and Growing Specialty Insurance Franchise Two pillars of a unique insurance platform with demonstrated improvement across specialty lines to complement market-leading agriculture franchise Enhanced Specialty Insurance Franchise Significant and tangible improvements in 201

  39. Slide 39: Demonstrated Track Record of Reinsurance Profitability

    Slide 39: Demonstrated Track Record of Reinsurance Profitability

    Demonstrated Track Record of Reinsurance Profitability Enhancing profitability by recruiting top flight underwriting talent, developing strategic partnerships with key clients and brokers, and improving underwriting and risk selection Reinsurance business has a demonstrated track record of profitabi

  40. Slide 40: Book Value Per Common Share Growth Comparison

    Slide 40: Book Value Per Common Share Growth Comparison

    Book Value Per Common Share Growth Comparison Endurance Growth in Diluted Book Value Per Common Share ($) From December 31, 2003 – December 31, 2013 10 Year CAGR: 10.6%, 5 Year CAGR: 13.0% $80 $60 10.85 7.13 8.33 9.57 6.13 $40 4.13 1.13 5.13 3.13 0.32 2.13 52.74 50.56 52.88 55.18 $20 44.61 27.91 28.

  41. Slide 41: Top Shareholders of Aspen

    Slide 41: Top Shareholders of Aspen

    Top 25 Shareholders of Aspen (1) Substantial overlap between shareholder bases Firm Aspen Votable Shares (1) % of O/S (2) Endurance Votable Shares (1) % of O/S (2) BlackRock Institutional Trust Co. NA 4,645,566 7.1% 1,441,700 3.3% Fidelity Investments 4,511,868 6.9% 3,952,400 9.1% Vanguard Group 3,8

  42. Slide 42: Aspen Management Team and Board Are Not Closely Aligned With Shareholders

    Slide 42: Aspen Management Team and Board Are Not Closely Aligned With Shareholders

    Aspen Management Team and Board Are Not Closely Aligned With Shareholders Endurance Director / Named Executive Officer Ownership Summary Number of Mkt. Value Name Role Common Shares (1) % Ownership (2) ($MM) (3) John Charman Chairman and CEO 1,674,315 3.85 90.1 Robert Spass Director 144,708 0.33 7.8

  43. Slide 43: Summary of Bridge Term Loan Facility Material Terms

    Slide 43: Summary of Bridge Term Loan Facility Material Terms

    Summary of Bridge Term Loan Facility Material Terms Facility Lenders Commitment Termination Date Maturity Pricing Prepayments Financial Covenants Conditions $1.0Bn 364-Day Senior Unsecured Bridge Term Loan Facility Syndicate led by Morgan Stanley December 31, 2014, or if an acquisition agreement is

  44. Slide 44: Continued Support from Equity Investor

    Slide 44: Continued Support from Equity Investor

    Continued Support from Equity Investor Endurance and CVC have terminated the previously announced equity commitment letter, which had been developed under the context of a friendly, negotiated transaction Since Aspen’s board and management have refused to engage with Endurance, Endurance was compell

  45. Slide 45: Endurance and Aspen: Creating a Global Leader in Specialty Insurance and Reinsurance

    Slide 45: Endurance and Aspen: Creating a Global Leader in Specialty Insurance and Reinsurance

    Endurance and Aspen: Creating a Global Leader in Specialty Insurance and Reinsurance Endurance 45

Source: SEC EDGAR · 425 filed Jul 1, 2014

More decks from Aspen Insurance Holdings Ltd

All 74 Aspen Insurance decks